The ATEV™ was observed to have superior duration of use over 24 months compared to autogenous fistula in high-need subgroups with historically poor outcomes with AV fistula procedures – – The ...

Vista Gold Corp. (NYSE American and TSX: VGZ) today announced its unaudited financial results for the quarter ended September ...

ACCESS Newswire Inc (ACCS) reports a 2% revenue increase and significant EBITDA growth, while focusing on expanding its ...